These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 7859770

  • 1. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
    de Kerviler E, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M.
    Eur J Nucl Med; 1994 Nov; 21(11):1191-7. PubMed ID: 7859770
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE).
    Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Ruszniewski P, Le Guludec D, Mignon M.
    Gut; 1997 Jul; 41(1):107-14. PubMed ID: 9274481
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
    Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT.
    Ann Intern Med; 1996 Jul 01; 125(1):26-34. PubMed ID: 8644985
    [Abstract] [Full Text] [Related]

  • 4. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
    Weinel RJ, Kisker O, Joseph K, Welcke U, Zaraca F, Rothmund M.
    Chirurg; 1994 Oct 01; 65(10):849-55. PubMed ID: 7821043
    [Abstract] [Full Text] [Related]

  • 5. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Groupe D'etude Du Syndrome De Zollinger-Ellison.
    Cadiot G, Lebtahi R, Sarda L, Bonnaud G, Marmuse JP, Vissuzaine C, Ruszniewski P, Le Guludec D, Mignon M.
    Gastroenterology; 1996 Oct 01; 111(4):845-54. PubMed ID: 8831579
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin receptor scintigraphy in gastrinomas.
    Jensen RT, Gibril F.
    Ital J Gastroenterol Hepatol; 1999 Oct 01; 31 Suppl 2():S179-85. PubMed ID: 10604126
    [Abstract] [Full Text] [Related]

  • 7. What is a false-positive somatostatin receptor scintigraphy?
    Reubi JC.
    J Nucl Med; 1998 Dec 01; 39(12):2193-4. PubMed ID: 9867170
    [No Abstract] [Full Text] [Related]

  • 8. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
    Lebtahi R, Cadiot G, Delahaye N, Genin R, Daou D, Peker MC, Chosidow D, Faraggi M, Mignon M, Le Guludec D.
    J Nucl Med; 1999 Oct 01; 40(10):1602-8. PubMed ID: 10520698
    [Abstract] [Full Text] [Related]

  • 9. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA, Hofland LJ, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Bakker WH, Kwekkeboom DJ, Visser TJ, Lamberts SW.
    Eur J Nucl Med; 1994 Apr 01; 21(4):328-35. PubMed ID: 7911760
    [Abstract] [Full Text] [Related]

  • 10. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
    Shi W, Johnston CF, Buchanan KD, Ferguson WR, Laird JD, Crothers JG, McIlrath EM.
    QJM; 1998 Apr 01; 91(4):295-301. PubMed ID: 9666953
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gastrinoma: advances in localization and treatment.
    Norton JA.
    Surg Oncol Clin N Am; 1998 Oct 01; 7(4):845-61. PubMed ID: 9735137
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
    Termanini B, Gibril F, Doppman JL, Reynolds JC, Stewart CA, Sutliff VE, Venzon DJ, Jensen RT.
    Radiology; 1997 Jan 01; 202(1):151-8. PubMed ID: 8988205
    [Abstract] [Full Text] [Related]

  • 17. Use of an isotopic somatostatin receptor probe to image gut endocrine tumors.
    Modlin IM, Cornelius E, Lawton GP.
    Arch Surg; 1995 Apr 01; 130(4):367-73; discussion 373-4. PubMed ID: 7710334
    [Abstract] [Full Text] [Related]

  • 18. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
    Alexander HR, Fraker DL, Norton JA, Bartlett DL, Tio L, Benjamin SB, Doppman JL, Goebel SU, Serrano J, Gibril F, Jensen RT.
    Ann Surg; 1998 Aug 01; 228(2):228-38. PubMed ID: 9712569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison.
    Cadiot G, Houillier P, Allouch A, Paillard M, Mignon M.
    Gut; 1996 Aug 01; 39(2):273-8. PubMed ID: 8977343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.